It appears medical transcription venture's third-quarter results will remain private
New capital covers growth-related costs
But former health secretary says that might require some good-cop, bad-cop from the White House
Dallas company looks to cross-sell lean, six sigma techniques
Prescription Assistance Program to increase Rx access
CEO, CFO both out at large doctor group
Acquired CONs for almost 300 beds moving forward
A.J. Kazimi talks about Cumberland Pharmaceuticals' low-risk strategy and the need to set a precedent [From our print edition featured in Monday's City Paper]
Company expects to double employee ranks
Exec scuttles IPO question; East Coast division posting strongest numbers
All Articles